Editing Database: DESCAR-T (France)

<span style="display:none">forresearchers</span> <span style="display:none">francecountry</span>
Go back to [[France]] page

'''Type of database:''' [[databaseType::registry]].

'''Primary purpose:''' To assess the overall survival of patients eligible for CAR-T therapy. The secondary goals are: (i) to evaluate the overall survival of patients who have undergone CAR-T treatment, (ii) to assess the effectiveness of CAR-T in real-world settings, and (iii) to examine both the short-term and long-term safety profile of CAR-T in real-life conditions.

'''Sponsor, manager, or home institution:''' [[dataOwner::LYSARC]].

'''Type of information:''' [[databaseStructure::longitudinal]]. Comprehensive data on patients treated with Chimeric Antigen Receptor T (CAR-T) cells for hematological malignancies. It includes patient demographics (age, gender, weight), clinical characteristics (tumor types, disease stage, ECOG performance status), treatment details (pre- and post-CAR-T protocols, infusion specifics), adverse events (toxicity and side effects), relapse data, and vital status (survival outcomes and overall survival rates). [https://www.ipaac.eu/roadmap/detail/50?utm_source=chatgpt.com Click here to learn more].

'''Source of information:''' Medical records from participating hospitals in France.

'''Data level:''' [[dataLevel::patient level]].

'''Number of records:''' [[numberRecords::748]] as of April 2021.

'''Date range:''' [[dataStart::2019]] [[dataEnd::onwards]].

'''Cancer areas of interest:''' [[hasCancerType::C81-C96: Cancers of the blood and immune system]]. [https://www.ipaac.eu/roadmap/detail/50?utm_source=chatgpt.com Click here to learn more].

'''Data access:''' [[dataAvailability::not publicly available]]. [[hasGrantRequirement::Data requires a grant proposal to be accessed]]. Instructions to request data for restricted content: [[hasDataAccessInstructions::[https://www.ipaac.eu/roadmap/detail/50?utm_source=chatgpt.com Click here to access in "Contact" section]]].

'''Contact information:''' [https://www.ipaac.eu/roadmap/detail/50?utm_source=chatgpt.com Click here to learn more].


<span style="display:none">databaseType::registry</span>
<span style="display:none">isDatabase</span>
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
<span style="display:none">Lymphatic</span>
<span style="display:none">Lymphoid</span>
<span style="display:none">Lymphoma</span>
<span style="display:none">Hematologic</span>
<span style="display:none">Hematopoietic</span>
<span style="display:none">Myeloma</span>
<span style="display:none">Plasma cell</span>